Zyprexa, the schizophrenia and bipolar drug manufactured by Eli Lilly, is now being considered in an injectable form every two to three weeks. The injection would be administered in a doctor’s office. In spite of the drug’s association with diabetes, the main concern with the longer acting form of the drug is a severe form of sleepiness.